JPH06506365A - 患者の血液から非溶解性脂肪質を除去する方法及び装置 - Google Patents
患者の血液から非溶解性脂肪質を除去する方法及び装置Info
- Publication number
- JPH06506365A JPH06506365A JP4502861A JP50286192A JPH06506365A JP H06506365 A JPH06506365 A JP H06506365A JP 4502861 A JP4502861 A JP 4502861A JP 50286192 A JP50286192 A JP 50286192A JP H06506365 A JPH06506365 A JP H06506365A
- Authority
- JP
- Japan
- Prior art keywords
- blood
- container
- lipids
- essentially
- repelling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000004369 blood Anatomy 0.000 title claims description 127
- 239000008280 blood Substances 0.000 title claims description 127
- 238000000034 method Methods 0.000 title claims description 31
- 150000002632 lipids Chemical class 0.000 claims description 52
- 230000001846 repelling effect Effects 0.000 claims description 33
- -1 polyethylene Polymers 0.000 claims description 11
- 239000011148 porous material Substances 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- 210000000988 bone and bone Anatomy 0.000 claims description 7
- 239000004698 Polyethylene Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 230000002209 hydrophobic effect Effects 0.000 claims description 5
- 229920000573 polyethylene Polymers 0.000 claims description 5
- 208000007536 Thrombosis Diseases 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 4
- 230000002940 repellent Effects 0.000 claims description 4
- 239000005871 repellent Substances 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000002033 PVDF binder Substances 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 claims description 2
- 238000007599 discharging Methods 0.000 claims description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 claims description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 2
- SCUZVMOVTVSBLE-UHFFFAOYSA-N prop-2-enenitrile;styrene Chemical compound C=CC#N.C=CC1=CC=CC=C1 SCUZVMOVTVSBLE-UHFFFAOYSA-N 0.000 claims description 2
- 229920000638 styrene acrylonitrile Polymers 0.000 claims description 2
- MIZLGWKEZAPEFJ-UHFFFAOYSA-N 1,1,2-trifluoroethene Chemical group FC=C(F)F MIZLGWKEZAPEFJ-UHFFFAOYSA-N 0.000 claims 1
- 230000004069 differentiation Effects 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 229920000915 polyvinyl chloride Polymers 0.000 claims 1
- 239000004800 polyvinyl chloride Substances 0.000 claims 1
- 239000003925 fat Substances 0.000 description 45
- 238000011282 treatment Methods 0.000 description 12
- 238000001356 surgical procedure Methods 0.000 description 8
- 230000000399 orthopedic effect Effects 0.000 description 6
- 239000012530 fluid Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 150000003626 triacylglycerols Chemical class 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 238000007667 floating Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000003241 Fat Embolism Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000011882 arthroplasty Methods 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000011976 chest X-ray Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002297 emergency surgery Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000013150 knee replacement Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007971 neurological deficit Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3627—Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
- A61M1/3633—Blood component filters, e.g. leukocyte filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/60—Containers for suction drainage, adapted to be used with an external suction source
- A61M1/61—Two- or three-bottle systems for underwater drainage, e.g. for chest cavity drainage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/08—Lipoids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/08—Supports for equipment
- A61M2209/082—Mounting brackets, arm supports for equipment
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- External Artificial Organs (AREA)
- Fats And Perfumes (AREA)
Abstract
Description
Claims (23)
- 1.患者の血液を再使用するため処理する装置であって、(a)患者の身体から の血液を受入れる容器と、(b)血液から非溶解性の脂質を除去するため容器の 中に配設された脂肪除去手段であって、血液中の本質的に非溶解性の脂質と血液 の本質的に水性の成分との間を弁別することができ非溶解性の脂質と接触する親 脂性の弁別手段を有し、さらに本質的に非溶解性の脂質を蓄積する手段を有して いる、脂肪除去手段、とを具備している血液処理装置。
- 2.前記脂肪除去手段がはじき出し手段を具備している請求項1に記載の装置。
- 3.前記親脂性はじき出し手段が、ポリエチレン、ポリプロピレン、ポリスチレ ン、ポリ塩化ビニール、ポリ弗化ビニリデン、ポリエステル、エチレン−ビニー ルアセテート、ポリテトラフルオロエチレン、スチレン−アクリロニトリル、テ トラフルオロエチレン、及びシリコンからなる群から選択された重合体材料で構 成されている請求の範囲第2項記載の装置。
- 4.前記はじき出し手段が重合体ポリエチレンで構成されている請求の範囲第2 項記載の装置。
- 5.前記はじき出し手段が重合体材料で構成されている請求の範囲第2項記載の 装置。
- 6.前記はじき出し手段が容器の中に配置するようになっているほぼ垂直の手段 を具備し、それにより、血液の増加した容量が容器に受け入れられると、血液の 上面がはじき出し手段の順次高い部分に接触するようになり、はじき出し手段が 血液上面より上方に突出し、血液の上面から出ているはじき出し手段の突出部分 の最も近くで血液の上面の本質的に非溶解性の脂質がはじき出し手段の部分に接 触するのを容易にするようにしている請求の範囲第1項から第5項のうちの1項 に記載の装置。
- 7.容器が、血液の本質的に水性の成分のための開放した流入端部と閉鎖した放 出端部とを有している請求項6に記載の装置。
- 8.前記はじき出し手段が三次元の固い構造を具備している請求の範囲第1項か ら第5項のうちの1項に記載の装置。
- 9.前記はじき出し手段が、通常の輸血圧力のもとで血液の本質的に水性の成分 の通過に対しては孔のないように構成されている請求の範囲第6項に記載の装置 。
- 10.前記固い構造が、通常の輸血圧力のもとで血液の通過に対し孔のない状態 とするような細孔の大きさの横断面構造を有している請求の範囲第8項記載の装 置。
- 11.容器に分配される血液を阻止するため装置の一部としてフィルターが設け られ、該フィルターが容器に流入する全ての血液がこれを通過するよう配置され 、該フィルターは、血液の固まり、骨の粒子その他をろ過する孔あき手段を有し また本質的に遊離した脂質の流れが通過するのを妨げるような十分な親水性かつ 疎脂性の特性を有している請求の範囲第1項から第5項のうちの1項に記載の装 置。
- 12.前記はじき出し手段と前記フィルターが、前記容器の中に受け入れられる 血液のための前記容器内の閉じた控えの室を区画形成し、前記はじき出し手段が 前記控えの室の少なくとも1つの壁部分を具備している請求の範囲第11項記載 の装置。
- 13.前記はじき出し手段が、血液の中の本質的に非溶解性の脂質と血液の中の 本質的に水性の成分との間の弁別を容易にするため250ミクロンまでの細孔の 大きさを有している請求の範囲第1項から第5項のうちの1項に記載の装置。
- 14.細孔の大きさが10〜100ミクロンの範囲内である請求の範囲第13項 記載の装置。
- 15.容器から処理された血液を取出す浸漬チューブ手段を含んでいる請求の範 囲第1項から第5項のうちの1項に記載の装置。
- 16.前記脂肪除去手段もまた疎脂性弁別手段である請求の範囲第1項記載の装 置。
- 17.前記脂肪除去手段が、本質的に非溶解性の脂質をその中に分配する手段を 含んでいる請求の範囲第1項記載の装置。
- 18.再使用のため患者の血液を処理する方法であって、(a)患者の身体から の血液を受け入れるための容器を用意する段階と、 (b)患者の血液を容器に分配する段階と、(c)血液を、血液中の本質的に非 溶解性の脂質と血液中の本質的に水性の成分との間を弁別することのできる親脂 性の弁別手段に接触させることにより、容器の中の血液から本質的に非溶解性の 脂質を除去し、該本質的に非溶解性の脂質を蓄積する段階、とからなる血液の処 理方法。
- 19.血液と弁別手段との接触が、血液をはじき出し手段に接触させ非溶解性の 脂質を残りの血液からはじき出すことを含んでいる請求の範囲第18項記載の方 法。
- 20.はじき出し手段を容器の中にはぼ垂直に配置し、容器の中の血液の増加す る液面がその上に担持された本質的に非溶解性の脂質を有する上面を有し、該上 面を貫通してはじき出し手段が容器内の血液の増加する液面の上方に突出する段 階を含んでいる請求の範囲第19項記載の方法。
- 21.血液から血の固まり、骨の破片その他を除去するため血液をろ過する段階 を含んでいる請求の範囲第18項から第20項のうちの1項に記載の方法。
- 22.血液と接触する段階が血液を疎水性の弁別手段に接触させることを含んで いる請求の範囲第18項記載の方法。
- 23.本質的に非溶解性の脂質を脂肪除去媒体の中に分配する段階を含んでいる 請求項18に記載の方法。
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US626,895 | 1990-12-13 | ||
| US07/626,895 US5133703A (en) | 1986-02-18 | 1990-12-13 | Process and apparatus for collecting blood of a patient for autotransfusion |
| US778,583 | 1991-10-17 | ||
| US07/778,583 US5203778A (en) | 1986-02-18 | 1991-10-17 | Process and apparatus for removal of insoluble fat from blood of a patient |
| PCT/US1991/009291 WO1992010219A1 (en) | 1990-12-13 | 1991-12-05 | Process and apparatus for removing insoluble fat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH06506365A true JPH06506365A (ja) | 1994-07-21 |
Family
ID=27090277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4502861A Expired - Lifetime JPH06506365A (ja) | 1990-12-13 | 1991-12-05 | 患者の血液から非溶解性脂肪質を除去する方法及び装置 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5203778A (ja) |
| EP (1) | EP0561958B1 (ja) |
| JP (1) | JPH06506365A (ja) |
| AT (1) | ATE134513T1 (ja) |
| AU (1) | AU661668B2 (ja) |
| CA (1) | CA2095325C (ja) |
| DE (1) | DE69117530T2 (ja) |
| WO (1) | WO1992010219A1 (ja) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5354262A (en) * | 1986-02-18 | 1994-10-11 | Boehringer Laboratories | Apparatus for removal of insoluble fat from blood of a patient |
| US5735290A (en) * | 1993-02-22 | 1998-04-07 | Heartport, Inc. | Methods and systems for performing thoracoscopic coronary bypass and other procedures |
| US5744038A (en) | 1993-07-30 | 1998-04-28 | Aruba International Pty Ltd. | Solvent extraction methods for delipidating plasma |
| AUPN030794A0 (en) | 1994-12-22 | 1995-01-27 | Aruba International Pty Ltd | Discontinuous plasma or serum delipidation |
| US5634893A (en) * | 1995-04-24 | 1997-06-03 | Haemonetics Corporation | Autotransfusion apparatus |
| US5653888A (en) * | 1995-11-02 | 1997-08-05 | Arbor Technologies, Inc. | Fluid filter assembly including gel removing barbs |
| US5879624A (en) * | 1997-01-15 | 1999-03-09 | Boehringer Laboratories, Inc. | Method and apparatus for collecting and processing blood |
| US7407662B2 (en) | 2000-06-29 | 2008-08-05 | Lipid Sciences, Inc. | Modified viral particles with immunogenic properties and reduced lipid content |
| US7407663B2 (en) | 2000-06-29 | 2008-08-05 | Lipid Sciences, Inc. | Modified immunodeficiency virus particles |
| US20090017069A1 (en) * | 2000-06-29 | 2009-01-15 | Lipid Sciences, Inc. | SARS Vaccine Compositions and Methods of Making and Using Them |
| US7439052B2 (en) * | 2000-06-29 | 2008-10-21 | Lipid Sciences | Method of making modified immunodeficiency virus particles |
| AUPQ846900A0 (en) * | 2000-06-29 | 2000-07-27 | Aruba International Pty Ltd | A vaccine |
| US6884228B2 (en) | 2001-03-06 | 2005-04-26 | Baxter International Inc. | Automated system adaptable for use with different fluid circuits |
| US6706008B2 (en) | 2001-03-06 | 2004-03-16 | Baxter International Inc. | Automated system and method for withdrawing compounds from blood |
| US6582386B2 (en) | 2001-03-06 | 2003-06-24 | Baxter International Inc. | Multi-purpose, automated blood and fluid processing systems and methods |
| WO2003000381A1 (en) * | 2001-06-25 | 2003-01-03 | Lipid Sciences, Inc. | Hollow fiber contactor systems for removal of lipids from fluids |
| EP1412045A4 (en) * | 2001-06-25 | 2007-05-02 | Lipid Sciences Inc | A SOLVENT FOR REMOVING LIPIDES FROM FLUIDS USING SYSTEMS AND METHOD |
| US20060060520A1 (en) * | 2001-06-25 | 2006-03-23 | Bomberger David C | Systems and methods using a solvent for the removal of lipids from fluids |
| US20030127386A1 (en) * | 2001-06-25 | 2003-07-10 | Bomberger David C. | Hollow fiber contactor systems for removal of lipids from fluids |
| US6991727B2 (en) * | 2001-06-25 | 2006-01-31 | Lipid Sciences, Inc. | Hollow fiber contactor systems for removal of lipids from fluids |
| SE523410C2 (sv) * | 2002-02-08 | 2004-04-13 | Estr Engstrom Scient And Techn | Apparat för reducering av fettinnehåll i blod |
| EP1534243A4 (en) * | 2002-08-26 | 2008-08-13 | Lipid Sciences Inc | TREATMENT OF ALZHEIMER WITH ENTLIPIDED PROTEIN PARTICLES |
| US7393826B2 (en) | 2003-07-03 | 2008-07-01 | Lipid Sciences, Inc. | Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
| DK1641421T3 (en) * | 2003-07-03 | 2019-03-11 | Hdl Therapeutics Inc | Methods and apparatus for producing HDL particle derivatives of reduced lipid content |
| US6960803B2 (en) * | 2003-10-23 | 2005-11-01 | Silicon Storage Technology, Inc. | Landing pad for use as a contact to a conductive spacer |
| US8591952B2 (en) * | 2006-10-10 | 2013-11-26 | Massachusetts Institute Of Technology | Absorbant superhydrophobic materials, and methods of preparation and use thereof |
| AU2015202206B2 (en) * | 2008-02-29 | 2017-03-02 | Solventum Intellectual Properties Company | A system and method for collecting exudates |
| EP3033356B1 (en) | 2013-08-14 | 2020-01-15 | Sachdev Sidhu | Antibodies against frizzled proteins and methods of use thereof |
| US11027052B2 (en) | 2017-11-22 | 2021-06-08 | HDL Therapuetics, Inc. | Systems and methods for priming fluid circuits of a plasma processing system |
| EP3731814A4 (en) | 2017-12-28 | 2021-09-29 | HDL Therapeutics, Inc. | METHOD OF PRESERVATION AND ADMINISTRATION OF HIGH DENSITY PRE-BETA LIPOPROTEIN EXTRACTED FROM HUMAN PLASMA |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4572724A (en) * | 1984-04-12 | 1986-02-25 | Pall Corporation | Blood filter |
| US4655754A (en) * | 1984-11-09 | 1987-04-07 | Stryker Corporation | Vacuum wound drainage system and lipids baffle therefor |
| US4775482A (en) * | 1985-05-28 | 1988-10-04 | Mederi Medical Systems, Inc. | Method for removing fat and for purifying and defoaming liquids |
| AU594964B2 (en) * | 1985-07-15 | 1990-03-22 | Aruba International Pty Ltd | Autologous plasma delipidation using a continuous flow system |
| US4994022A (en) * | 1989-02-02 | 1991-02-19 | Stryker Corporation | Blood conservation system |
-
1991
- 1991-10-17 US US07/778,583 patent/US5203778A/en not_active Expired - Lifetime
- 1991-12-05 CA CA002095325A patent/CA2095325C/en not_active Expired - Fee Related
- 1991-12-05 EP EP92901572A patent/EP0561958B1/en not_active Expired - Lifetime
- 1991-12-05 AU AU91378/91A patent/AU661668B2/en not_active Ceased
- 1991-12-05 JP JP4502861A patent/JPH06506365A/ja not_active Expired - Lifetime
- 1991-12-05 DE DE69117530T patent/DE69117530T2/de not_active Expired - Fee Related
- 1991-12-05 WO PCT/US1991/009291 patent/WO1992010219A1/en not_active Ceased
- 1991-12-05 AT AT92901572T patent/ATE134513T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69117530T2 (de) | 1996-08-29 |
| CA2095325A1 (en) | 1992-06-14 |
| AU9137891A (en) | 1992-07-08 |
| EP0561958A4 (en) | 1993-12-08 |
| ATE134513T1 (de) | 1996-03-15 |
| DE69117530D1 (de) | 1996-04-04 |
| WO1992010219A1 (en) | 1992-06-25 |
| EP0561958B1 (en) | 1996-02-28 |
| AU661668B2 (en) | 1995-08-03 |
| CA2095325C (en) | 1999-09-14 |
| US5203778A (en) | 1993-04-20 |
| EP0561958A1 (en) | 1993-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH06506365A (ja) | 患者の血液から非溶解性脂肪質を除去する方法及び装置 | |
| US5354262A (en) | Apparatus for removal of insoluble fat from blood of a patient | |
| US3593854A (en) | Blood treating and filtering apparatus | |
| US5133703A (en) | Process and apparatus for collecting blood of a patient for autotransfusion | |
| US5100376A (en) | Body-cavity drainage and autotransfusion system | |
| EP0327136B1 (en) | Blood filter | |
| AU696270B2 (en) | A filtration device usable for removal of leukocytes and other blood components | |
| US8241264B2 (en) | Method and apparatus for autotransfusion | |
| US5049146A (en) | Blood/gas separator and flow system | |
| CN112292161B (zh) | 过滤器组件和包含过滤器组件的用于收集血液的容器 | |
| EP0745398A2 (en) | Cardiotomy reservoir with internal filter | |
| JPH08500509A (ja) | 処理済み血液製剤から目的外の流体を除去するための方法および装置 | |
| JP2007514456A (ja) | 灌注並びに組織排出及び収集システム及びその方法 | |
| WO2010041604A1 (ja) | 貯血槽 | |
| JPH05506596A (ja) | 自家輸血装置用真空システム | |
| JP2010088737A (ja) | 貯血槽 | |
| JPS61502946A (ja) | 自己輸注装置およびその使用方法 | |
| EP0604590A4 (en) | Gas plasma treated porous medium and method of separation using same. | |
| JP5293066B2 (ja) | フィルタ部材、貯血槽 | |
| JPH01501528A (ja) | 体液捕集装置および方法 | |
| JPH03173824A (ja) | 白血球分離器 | |
| JPH0717872A (ja) | 血液分離システム | |
| JP3635654B2 (ja) | 血液成分採取器具 | |
| JP3758012B2 (ja) | 血液成分採取方法およびその採取器具 | |
| JP4043102B2 (ja) | 体外循環回路用チャンバー |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090516 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100516 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110516 Year of fee payment: 14 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110516 Year of fee payment: 14 |